The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus
Hao Yin, Xi-tong Chen, Qiao-na Chi, Yan‐Nan Ma, Xing‐Yan Fu, Shanshan Du, Yun‐Kun Qi, Kewei Wang
Topics & Concepts
Oncolytic virusCancer cellApoptosisCancer researchChemistryCytoplasmPeptideNucleusCancerMolecular biologyBiochemistryCell biologyBiologyMedicineInternal medicineTumor cellsAntimicrobial Peptides and ActivitiesRNA Interference and Gene DeliveryRNA and protein synthesis mechanisms